Masakazu Aihara, Naoto Kubota. Glycated albumin: An old yet new biomarker in people with diabetes and the potential for novel applications. // Journal of Diabetes Investigation. – 2026. – DOI: 10.1111/jdi.70447. – URL: https://onlinelibrary.wiley.com/doi/10.1111/jdi.70447?af=R
Masakazu Aihara & Naoto Kubota (2026). Glycated albumin: An old yet new biomarker in people with diabetes and the potential for novel applications. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70447
Masakazu Aihara and Naoto Kubota. “Glycated albumin: An old yet new biomarker in people with diabetes and the potential for novel applications.” Journal of Diabetes Investigation, 2026. doi:10.1111/jdi.70447.
@article{Aihara2026,
title = {Glycated albumin: An old yet new biomarker in people with diabetes and the potential for novel applications},
author = {Aihara, Masakazu and Kubota, Naoto},
journal = {Journal of Diabetes Investigation},
year = {2026},
doi = {10.1111/jdi.70447},
url = {https://onlinelibrary.wiley.com/doi/10.1111/jdi.70447?af=R}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...